Identification of 20(

Yuan Liang, Jingqi Zhao, Haoyang Zou, Jie Zhang, Tiehua Zhang

Open access · hybridAbstract read

In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

0.5field-weighted citation impact, top 40% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

The molecular mechanism of ginsenoside Rh2 and its octyl ester derivative on anti-angiogenesis in cancer treatment: The battle between PI3K and ROS.Journal of ginseng research · 2025
Article
Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen.ACS pharmacology & translational science · 2022
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yuan LiangCollege of Food Science and Engineering, Jilin University, Changchun 130062, China.ORCID https://orcid.org/0000-0002-8473-8154

Jingqi ZhaoCollege of Food Science and Engineering, Jilin University, Changchun 130062, China.

Haoyang ZouCollege of Food Science and Engineering, Jilin University, Changchun 130062, China.

Jie ZhangCollege of Food Science and Engineering, Jilin University, Changchun 130062, China.ORCID https://orcid.org/0000-0002-6944-2021

Tiehua ZhangCollege of Food Science and Engineering, Jilin University, Changchun 130062, China.ORCID https://orcid.org/0000-0001-9724-9432

Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the main active ingredients of

Indexed as

Binding SitesCell Line, TumorCell MovementCell ProliferationErbB ReceptorsG1 Phase Cell Cycle CheckpointsGinsenosidesHumansMolecular Docking SimulationMolecular Dynamics SimulationPanaxProtein Kinase InhibitorsStructure-Activity RelationshipErbB Receptorsginsenoside Rh2GinsenosidesProtein Kinase Inhibitors

Identifiers

PMID35111279

DOI10.1155/2022/6119737

PMCPMC8803441

OpenAlexW4210587412

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.